Journal article
A panoply of errors: polymerase proofreading domain mutations in cancer
- Abstract:
- Although it has long been recognized that the exonucleolytic proofreading activity intrinsic to the replicative DNA polymerases Pol δ and Pol ε is essential for faithful replication of DNA, evidence that defective DNA polymerase proofreading contributes to human malignancy has been limited. However, recent studies have shown that germline mutations in the proofreading domains of Pol δ and Pol ε predispose to cancer, and that somatic Pol ε proofreading domain mutations occur in multiple sporadic tumours, where they underlie a phenotype of 'ultramutation' and favourable prognosis. In this Review, we summarize the current understanding of the mechanisms and consequences of polymerase proofreading domain mutations in human malignancies, and highlight the potential utility of these variants as novel cancer biomarkers and therapeutic targets.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 741.4KB, Terms of use)
-
- Publisher copy:
- 10.1038/nrc.2015.12
Authors
- Publisher:
- Nature Research
- Journal:
- Nature Reviews Cancer More from this journal
- Volume:
- 16
- Issue:
- 2016
- Pages:
- 71-81
- Publication date:
- 2016-01-29
- Acceptance date:
- 2015-12-09
- DOI:
- EISSN:
-
1474-1768
- ISSN:
-
1474-175X
- Keywords:
- Pubs id:
-
pubs:596812
- UUID:
-
uuid:cbbc678a-6f1c-415e-82c9-e664369e8097
- Local pid:
-
pubs:596812
- Source identifiers:
-
596812
- Deposit date:
-
2016-01-25
Terms of use
- Copyright holder:
- Macmillan Publishers Limited
- Copyright date:
- 2016
- Notes:
- © 2016 Macmillan Publishers Limited. All rights reserved. This is the accepted manuscript version of the article. The final version is available from Nature Research at: https://doi.org/10.1038/nrc.2015.12
If you are the owner of this record, you can report an update to it here: Report update to this record